Cancer Immunotherapy Platform Targets Broad Range of Metastatic Cancers

California Stem Cell, Inc. has announced the completion of an internal study demonstrating that the company's proprietary immunotherapy manufacturing process can be applied to multiple cancer types.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130731005822&newsLang=en&ndmConfigId=1000639&vnsId=41